|
|
Article: INDIA'S NATCO RECALLS BREAST CANCER DRUG 'ALBUPAX'.
- Article from:
- AsiaPulse News
- Article date:
- July 20, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW DELHI, July 20 Asia Pulse - Indian drug firm Natco Pharma (BSE:524816) on Saturday said it has stopped the production and marketing of breast cancer drug 'Albupax', after tests showed that it might cause damage to the liver.
The Indian Health Regulator Drug Controller General of India (DCGI) DCGI has sent a letter to the company asking them to stop the production, distribution and marketing of the drug, according to sources.
"As per DCGI office, we have stopped marketing the product in the interim," Natco Pharma said in an e-mail response.
When asked about it, the company ...